Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

G1 control gene status is frequently altered in resectable non-small cell lung cancer.

International journal of cancer - 21 Oct 1997

Betticher D C, White G R, Vonlanthen S, Liu X, Kappeler A, Altermatt H J, Thatcher N, Heighway J

Abstract excerpt

Progression through the mammalian cell cycle is controlled by a series of cyclins, cyclin-dependent kinases (cdks) and cdk inhibitors. Cyclin D1, cdk4 and the tumour suppressors p16 and retinoblastoma protein (pRb) are thought to comprise a linked system governing cell passage through the G1 phase of the cell cycle. Extending an earlier study on cyclin D1 expression, a series of resectable non-small cell lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to DNA Methylation
Share to Down-Regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Lung Neoplasms

Share to Mutation

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 9355981
DOI: 10.1002/(sici)1097-0215(19971021)74:5<556::aid-ijc14>3.0.co;2-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

G1 control gene status is frequently altered in resectable non-small cell lung cancer.PMID 9355981Read ↗

Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.Semantic proximity Read ↗

Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancerSemantic proximity Read ↗

Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient SubsetSemantic proximity Read ↗

Analysis of cell cycle regulator proteins in non-small cell lung cancerSemantic proximity Read ↗

RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerSemantic proximity Read ↗

Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissueSemantic proximity Read ↗

Mechanism of Retinoblastoma Gene Inactivation in the Spectrum of Neuroendocrine Lung TumorsSemantic proximity Read ↗

Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival.Semantic proximity Read ↗

Retinoblastoma Regulatory Pathway in Lung CancerSemantic proximity Read ↗

Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.Semantic proximity Read ↗

Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma.Semantic proximity Read ↗

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.